• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Walgreens and Veeva Form Strategic Partnership

    10/24/24 8:00:00 AM ET
    $VEEV
    $WBA
    Computer Software: Prepackaged Software
    Technology
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $VEEV alert in real time by email

    DEERFIELD, Ill. and PLEASANTON, Calif., Oct. 24, 2024 /PRNewswire/ -- Walgreens (NASDAQ:WBA), an integrated healthcare, pharmacy, and retail leader, and Veeva Systems (NYSE:VEEV) a leading provider of software, data, and services for the life sciences industry, today announced a long-term partnership to help life sciences companies improve patient outcomes.

    Veeva Systems (PRNewsfoto/Veeva Systems)

    The partnership enriches Veeva Data Cloud products and allows Walgreens to better serve life sciences through access to Veeva Data Cloud and Veeva Clinical Platform.

    "As the front door to healthcare for most communities, Walgreens remains the independent partner of choice for life sciences companies looking to improve patient outreach and engagement," said Walgreens Boots Alliance CEO Tim Wentworth. "Collaborating across the industry, combining our unmatched retail pharmacy and specialty pharmacy strengths with best-in-class technology products, is another way we're making healthcare more connected in the U.S."

    "As a neighborhood health destination and modern pharmacy for millions, Walgreens plays a critical role in the healthcare ecosystem," said Veeva CEO Peter Gassner. "Partnering with Walgreens expands the breadth of data in Veeva Data Cloud, giving life sciences companies the high-quality data they need to better understand market trends and improve patient outcomes."

    About Walgreens

    Walgreens (www.walgreens.com) is included in the U.S. Retail Pharmacy and U.S. Healthcare segments of Walgreens Boots Alliance, Inc. (NASDAQ:WBA), an integrated healthcare, pharmacy and retail leader. True to its purpose of "more joyful lives through better health," Walgreens has a more than 120-year heritage of caring for communities and providing trusted pharmacy services, and today is playing a greater role as an independent partner of choice offering healthcare services that improve care, lower costs, and help patients. Operating nearly 9,000 retail locations across the U.S. and Puerto Rico, Walgreens is proud to serve nearly 9 million customers and patients daily. The company's pharmacists are playing a more critical role in healthcare than ever before, providing a wide range of pharmacy and healthcare services, including those that drive equitable access to care for some of the nation's most underserved populations. Walgreens offers customers and patients a true omnichannel experience, with fully integrated physical and digital platforms designed to deliver high-quality products and healthcare services. Within the U.S. Healthcare segment, Walgreens portfolio also includes businesses in primary care, multi-specialty, post-acute care, urgent care, specialty pharmacy services, population health and provider enablement.

    About Veeva Systems

    Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

    Media Contacts:







    Maria Scurry

    Jonathon Hosea

    Veeva Systems

    [email protected]

    781-366-7617

    Walgreens 

    [email protected] 

     

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/walgreens-and-veeva-form-strategic-partnership-302285679.html

    SOURCE Veeva Systems

    Get the next $VEEV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What partnership was announced on October 24, 2024?

      Walgreens and Veeva Systems have announced a long-term partnership to help life sciences companies improve patient outcomes.

    • How will the partnership between Walgreens and Veeva Systems benefit life sciences companies?

      The partnership will enhance Veeva Data Cloud products and enable Walgreens to better serve life sciences companies through improved access to data and technology.

    • What did Walgreens CEO Tim Wentworth say about the company's role in the healthcare ecosystem?

      Tim Wentworth, CEO of Walgreens Boots Alliance, emphasized the company's role as a choice partner for life sciences companies aiming to enhance patient engagement.

    • What specific capability does the partnership provide to Veeva Systems?

      The collaboration allows Veeva to expand the breadth of data available in Veeva Data Cloud, aiding life sciences companies in market trend analysis and patient outcome improvements.

    • How many retail locations does Walgreens operate, and what is its daily customer reach?

      Walgreens operates nearly 9,000 retail locations across the U.S., serving around 9 million customers and patients daily, and plays a critical role in healthcare delivery.

    Recent Analyst Ratings for
    $VEEV
    $WBA

    CompanyDatePrice TargetRatingAnalyst
    Veeva Systems Inc.
    $VEEV
    1/13/2026$215.00Sell
    Goldman
    Veeva Systems Inc.
    $VEEV
    1/8/2026Hold → Buy
    Truist
    Veeva Systems Inc.
    $VEEV
    12/12/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    Veeva Systems Inc.
    $VEEV
    11/13/2025$300.00Market Perform
    BMO Capital Markets
    Veeva Systems Inc.
    $VEEV
    10/7/2025$380.00Hold → Buy
    TD Cowen
    Veeva Systems Inc.
    $VEEV
    9/8/2025$330.00Neutral → Overweight
    Analyst
    Veeva Systems Inc.
    $VEEV
    5/29/2025$270.00 → $300.00Buy
    Needham
    Walgreens Boots Alliance Inc.
    $WBA
    2/28/2025$11.00 → $9.00Hold → Sell
    Deutsche Bank
    More analyst ratings

    $VEEV
    $WBA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman resumed coverage on Veeva Systems with a new price target

    Goldman resumed coverage of Veeva Systems with a rating of Sell and set a new price target of $215.00

    1/13/26 9:18:31 AM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    Veeva Systems upgraded by Truist

    Truist upgraded Veeva Systems from Hold to Buy

    1/8/26 9:27:19 AM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    Veeva Systems downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Veeva Systems from Overweight to Sector Weight

    12/12/25 8:43:57 AM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    $VEEV
    $WBA
    SEC Filings

    View All

    Veeva Systems Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - VEEVA SYSTEMS INC (0001393052) (Filer)

    1/5/26 4:04:59 PM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    Veeva Systems Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - VEEVA SYSTEMS INC (0001393052) (Filer)

    12/11/25 4:04:38 PM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-Q filed by Veeva Systems Inc.

    10-Q - VEEVA SYSTEMS INC (0001393052) (Filer)

    11/21/25 4:07:12 PM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    $VEEV
    $WBA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    13 of the Top 20 Biopharmas Standardize Globally on Veeva Link Key People

    Emerging biotechs and top biopharmas trust Link to power customer engagement and provide structured datasets to fuel AI initiatives PLEASANTON, Calif., Feb. 4, 2026 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced that 13 of the top 20 biopharmas have standardized on Veeva Link Key People to enhance customer engagement and provide data for AI globally. Biopharmas of all sizes use Link Key People, with 38 new customers added and three of the top 20 biopharmas making it their global standard within the last year. "Access to Veeva Link Key People further strengthens data

    2/4/26 7:03:00 AM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    Veeva Announces eSource Application for Research Sites to Eliminate Paper and Streamline Clinical Trial Data Flow

    Frees sites from duplicate data entry and connects EHR and EDC for higher quality trial data, faster PLEASANTON, Calif., Jan. 29, 2026 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced Veeva eSource, a new Veeva SiteVault application designed to significantly reduce manual clinical trial processes and increase data quality. Veeva eSource will eliminate paper at the site through a direct data capture application and streamline data through EDC integration, and EHR to EDC transfer. "I'm excited to see Veeva eSource in action; although there are other options in use by si

    1/29/26 8:00:00 AM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    Industry Research Finds Establishing a Foundation for AI is Top Priority for CPG Enterprises

    82% of organizations moving to unified platforms for standardized data and processes, AI readiness PLEASANTON, Calif., Jan. 27, 2026 /PRNewswire/ -- A new industry report shows that building an AI-ready infrastructure is a top priority for consumer product goods (CPG) companies. The State of AI in Consumer Goods Report found most (82%) respondents are actively consolidating legacy systems or transitioning from best-of-breed solutions into unified platforms. Moving to a platform can provide connectivity across systems for standardized data and processes, a critical requirement for applying AI use cases.

    1/27/26 7:03:00 AM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    $VEEV
    $WBA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chairman of Board Pessina Stefano sold $9,163,161 worth of shares (832,258 units at $11.01) and bought $9,163,161 worth of shares (832,258 units at $11.01), decreasing direct ownership by 56% to 657,308 units (SEC Form 4)

    4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)

    4/29/25 8:49:21 PM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Bhandari Inderpal S bought $54,150 worth of shares (3,000 units at $18.05) (SEC Form 4)

    4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)

    4/15/24 5:45:26 PM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Mahajan Manmohan bought $116,280 worth of shares (6,000 units at $19.38) (SEC Form 4)

    4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)

    4/2/24 6:40:23 PM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $VEEV
    $WBA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

    For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

    9/12/23 10:44:21 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $VEEV
    $WBA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres. & Chief Customer Officer Schwenger Thomas D. sold $231,430 worth of shares (1,000 units at $231.43), decreasing direct ownership by 4% to 23,204 units (SEC Form 4)

    4 - VEEVA SYSTEMS INC (0001393052) (Issuer)

    1/15/26 4:43:44 PM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    SVP, Gen. Counsel, Secretary Faddis Jonathan converted options into 1,225 shares and covered exercise/tax liability with 483 shares, increasing direct ownership by 26% to 3,609 units (SEC Form 4)

    4 - VEEVA SYSTEMS INC (0001393052) (Issuer)

    1/5/26 4:26:28 PM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    Chief Financial Officer Van Wagener Brian converted options into 871 shares and covered exercise/tax liability with 321 shares, increasing direct ownership by 8% to 7,881 units (SEC Form 4)

    4 - VEEVA SYSTEMS INC (0001393052) (Issuer)

    1/5/26 4:25:22 PM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    $VEEV
    $WBA
    Leadership Updates

    Live Leadership Updates

    View All

    Walgreen Co. To Operate as Private Standalone Company Following Acquisition By Sycamore Partners

    Appoints Mike Motz as Chief Executive Officer Walgreen Co. ("Walgreens", or the "Company"), America's leading independent retail pharmacy, announced today that it is now operating as a private standalone company following its acquisition by Sycamore Partners ("Sycamore"), a leading private equity firm based in New York. Sycamore is acquiring the business in partnership with Stefano Pessina and his family, who have reinvested 100% of their interests in Walgreens, demonstrating their ongoing support and confidence in the Company's future. Mike Motz has been appointed as Chief Executive Officer of Walgreens effective immediately. Motz was formerly CEO of Staples US Retail, a Sycamore por

    8/28/25 8:31:00 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Interactive Brokers Group Set to Join S&P 500, Talen Energy to Join S&P MidCap 400 and Kinetik Holdings to Join S&P SmallCap 600

    NEW YORK, Aug. 25, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600: S&P MidCap 400 constituent Interactive Brokers Group Inc. (NASD: IBKR) will replace Walgreens Boots Alliance Inc. (NASD: WBA) in the S&P 500, and Talen Energy Corp. (NASD: TLN) will replace Interactive Brokers Group in the S&P MidCap 400 effective prior to the opening of trading on Thursday, August 28. Sycamore Partners is acquiring Walgreens Boots Alliance in a deal expected to be completed soon, pending final closing conditions.  Kinetik Holdings Inc. (NYSE:KNTK) will replace Pacific Premier Bancorp Inc. (NASD: PPBI) in the S&P SmallCap 600 ef

    8/25/25 5:41:00 PM ET
    $COLB
    $IBKR
    $KNTK
    Major Banks
    Finance
    Investment Bankers/Brokers/Service
    Natural Gas Distribution

    Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer

    Stenta will lead B2B commercial growth strategy as the company strengthens its role as the first choice for community pharmacy and health services in the U.S. Walgreens, an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, today announced the appointment of Jason Stenta as SVP and chief commercial officer. In this new role, Stenta will lead the company's commercial growth strategy, driving development and commercialization of B2B healthcare services built on the company's core assets, and enhancing partnerships with payers, health system providers and life sciences companies. This press release features multimedia. View the full release

    10/7/24 8:00:00 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $VEEV
    $WBA
    Financials

    Live finance-specific insights

    View All

    Veeva Announces Fiscal 2026 Third Quarter Results

    Total Revenues of $811.2M, up 16% Year Over Year Subscription Services Revenues of $682.5M, up 17% Year Over Year PLEASANTON, Calif., Nov. 20, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, 2025. "Continuing to lead through innovation, Veeva AI delivers on our vision for industry-specific AI that will help the life sciences industry reach new levels of productivity and customer centricity," said CEO Peter Gassner. "Veeva AI

    11/20/25 4:05:00 PM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    Veeva to Release Fiscal 2026 Third Quarter Results on November 20, 2025

    PLEASANTON, Calif., Oct. 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its third quarter ending October 31, 2025 after market close on November 20, 2025. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com at approximately 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event:              Veeva Systems' Fiscal 2026 Third Quarter Results Conference Call Date:                Thursday, November 20, 2025 Time:                2:00 p.m. PT (5:

    10/30/25 4:05:00 PM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    Veeva Announces Fiscal 2026 Second Quarter Results

    Total Revenues of $789.1M, up 17% Year Over YearSubscription Services Revenues of $659.2M, up 17% Year Over Year PLEASANTON, Calif., Aug. 27, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2025. "It's exciting to see our vision of connected software, data, and business consulting for life sciences becoming a reality," said CEO Peter Gassner. "I am especially excited about the power of Veeva AI and Veeva Data Cloud to enable t

    8/27/25 4:05:00 PM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    $VEEV
    $WBA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Walgreens Boots Alliance Inc.

    SC 13G/A - Walgreens Boots Alliance, Inc. (0001618921) (Subject)

    10/18/24 12:45:41 PM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Walgreens Boots Alliance Inc.

    SC 13D/A - Walgreens Boots Alliance, Inc. (0001618921) (Filed by)

    8/20/24 4:05:58 PM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G/A filed by Veeva Systems Inc. (Amendment)

    SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)

    2/16/24 4:29:43 PM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology